Chapter
Investment in Chronic Kidney Disease Solution
A group of investors, including family offices, Carlos Slim, and Royalty Pharma chairman Pablo LaGretta, has put half a billion dollars into advancing a business trying to provide a solution for chronic kidney disease through clinical trials. The solution involves taking cells from a patient's kidney, growing and amplifying them, and re-injecting them into the patient to improve their EGFR.
Clips
A group of investors, including family offices, Carlos Slim, and Royalty Pharma's chairman, Pablo LaGretta, invested half a billion dollars in a business that aims to provide a solution for chronic kidney disease.
1:03:05 - 1:05:10 (02:04)
Summary
A group of investors, including family offices, Carlos Slim, and Royalty Pharma's chairman, Pablo LaGretta, invested half a billion dollars in a business that aims to provide a solution for chronic kidney disease. By using a patient's own body to heal their kidneys, the business hopes to help those with chronic kidney disease or on dialysis.
ChapterInvestment in Chronic Kidney Disease Solution
EpisodeE87: Emerging markets, Sri Lanka, 9.1% CPI, market sentiment, NASA's Webb telescope & more
PodcastAll-In with Chamath, Jason, Sacks & Friedberg
Space telescopes allow astronomers to capture light from far away without interference of the Earth's atmosphere, providing more accurate data for astrophysics research.
1:05:10 - 1:07:42 (02:32)
Summary
Space telescopes allow astronomers to capture light from far away without interference of the Earth's atmosphere, providing more accurate data for astrophysics research.